Edition:
United States

People: Calithera Biosciences Inc (CALA.OQ)

CALA.OQ on NASDAQ Stock Exchange Global Select Market

5.21USD
3:17pm EST
Change (% chg)

$0.06 (+1.17%)
Prev Close
$5.15
Open
$5.14
Day's High
$5.31
Day's Low
$5.09
Volume
34,770
Avg. Vol
64,852
52-wk High
$11.25
52-wk Low
$4.07

Hecht, Curtis 

Mr. Curtis C. Hecht is the Senior Vice President - Business and Corporate Development of Calithera Biosciences Inc. Mr. Hecht has served as our Senior Vice President of Business and Corporate Development since April 2014. From September 2013 to April 2014, Mr. Hecht served as Vice President of Business Development at inVentiv Health, a global healthcare commercialization and consulting services company. Since March 2011, he has also served as a Partner at DNA Ink, a life sciences business development and licensing firm. From June 2002 to February 2011, Mr. Hecht served in a number of roles at Hoffman La-Roche Inc., including as Global Alliance Director from 2008 to 2011 and Director of Global Business Development from 2006 to 2008. Mr. Hecht received a B.S. in Chemistry from California State University, Sacramento and an M.B.A. from Carnegie Mellon University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Susan Molineaux

760,939

Sumita Ray

1,263,060

Curtis Hecht

--

Christopher Molineaux

446,601

Keith Orford

648,708

Eric Sjogren

445,144
As Of  30 Dec 2017